CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients
Clinical trial NCT04608266 · TERMINATED
Trial details
- NCT number
- NCT04608266
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2021-09-27
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.